32% Time to first decision:
Time to first decision with review:
Acceptance to publication:
Impact Factor (JCR):
*median number of days
Aims and scope
European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients. With peer reviewed papers, features, conference reports and more on topics covering all aspects of hospital pharmacy from both a scientific and practice perspective, the journal aims to highlight innovations and developments in pharmaceutical and biomedical sciences, promoting safe, efficacious and cost-effective pharmaceutical care for hospital pharmacists to practise. For information about the European Journal of Hospital Pharmacy Editor-in-Chief Prof Phil Wiffen and his editorial team, please refer to the Editorial Board page.
Plan S compliance
European Journal of Hospital Pharmacy is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.
BMJ publishes EJHP on behalf of the European Association of Hospital Pharmacists.
Subscription; with hybrid open access option
Web of Science Core Collection: Science Citation Index Expanded, Medline, PubMed Central, Scopus, Embase (Excerpta Medica), Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Journal Statistics (2021)
Acceptance rate: 32%
Speed Time to first decision without review (median): 6 days Time to first decision with review (median): 59 days Time from acceptance to publication (median): 15 days
Impact Impact Factor category: Pharmacology and Pharmacy Impact Factor (JCR): 2.530 Impact Factor rank (JCR): 205/279 5 year Impact Factor: 2.091 Journal Citation Indicator (JCI): 0.4 Eigenfactor: 0.00137 Citescore: 2.3 Citescore rank: 12/36 Scimago Journal Rank (SJR): 0.392
Reach 2021 total content views: 110,565 2021 total Altmetric mentions: 607
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics
For all contact information please refer to the Contact us page.
Please refer to the Instructions for authors
Rights and permissions
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.